Revance Therapeutics Inc
- Fund Information and Directors
| Revance Therapeutics Inc |
| Firm |
|
| Fund # | |
| CIK # | 0001479290 |
| Sale | 2009-12-08
($36.2 M Offered, $36.2 M Sold)
|
| Fund | |
| Phone | 5107423400 |
| Address | 7555 Gateway Blvd
Newark, California 94560 |
| Source |
[EDGAR]
|
| Fund AUM and Sold ($M) |
|
|
| Fund Details |
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction | |
| Form D Offering |
| Filed | 2010-11-18 (D/A) |
| Exemption | 506 |
| Duration | One year or less |
| Revenue | Decline to Disclose |
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 212250122, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
315700359